Kevin M. Cottrell

Person

  • Cambridge, MA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 12,005,127
    • Issue date Jun 11, 2024
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds and methods of use

    • Patent number 11,999,727
    • Issue date Jun 4, 2024
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds and methods of use

    • Patent number 11,986,471
    • Issue date May 21, 2024
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Modulators of alpha-1 antitrypsin

    • Patent number 11,884,672
    • Issue date Jan 30, 2024
    • Vertex Pharmaceuticals Incorporated
    • Upul Keerthi Bandarage
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 11,813,267
    • Issue date Nov 14, 2023
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Modulators of alpha-1 antitrypsin

    • Patent number 11,623,924
    • Issue date Apr 11, 2023
    • Vertex Pharmaceuticals Incorporated
    • Upul Keerthi Bandarage
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds and methods of use

    • Patent number 11,492,350
    • Issue date Nov 8, 2022
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Compounds and methods of use

    • Patent number 11,077,101
    • Issue date Aug 3, 2021
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 11,021,465
    • Issue date Jun 1, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 11,008,305
    • Issue date May 18, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors

    • Patent number 10,973,830
    • Issue date Apr 13, 2021
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,786,512
    • Issue date Sep 29, 2020
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,501,439
    • Issue date Dec 10, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,442,791
    • Issue date Oct 15, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,391,095
    • Issue date Aug 27, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,258,627
    • Issue date Apr 16, 2019
    • Vertex Pharmaceutical Incorporated
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 10,076,521
    • Issue date Sep 18, 2018
    • Vertex Pharamceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted benzooxadiazole DNA-PK inhibitors

    • Patent number 9,987,284
    • Issue date Jun 5, 2018
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors and uses thereof

    • Patent number 9,925,188
    • Issue date Mar 27, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors for treatment of cancer

    • Patent number 9,878,993
    • Issue date Jan 30, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,592,232
    • Issue date Mar 14, 2017
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,376,448
    • Issue date Jun 28, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,359,380
    • Issue date Jun 7, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors

    • Patent number 9,340,557
    • Issue date May 17, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors

    • Patent number 9,296,701
    • Issue date Mar 29, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Benzimidazole analogues for the treatment or prevention of flavivir...

    • Patent number 8,765,731
    • Issue date Jul 1, 2014
    • Vertex Pharmaceuticals Incorporated
    • James A. Henderson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    • Patent number 8,691,758
    • Issue date Apr 8, 2014
    • Vertex Pharmaceuticals Incorporated
    • Shawn D. Britt
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of serine proteases

    • Patent number 8,575,208
    • Issue date Nov 5, 2013
    • Vertex Pharmaceuticals Incorporated
    • Luc Farmer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    • Patent number 8,536,136
    • Issue date Sep 17, 2013
    • Vertex Pharmaceuticals Incorporated
    • David Deininger
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

    • Patent number 8,524,906
    • Issue date Sep 3, 2013
    • Vertex Pharmaceuticals Incorporated
    • Alex Aronov
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN

    • Publication number 20240336614
    • Publication date Oct 10, 2024
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Upul Keerthi BANDARAGE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AND METHODS OF USE

    • Publication number 20240279219
    • Publication date Aug 22, 2024
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS AND METHODS OF USE

    • Publication number 20240228478
    • Publication date Jul 11, 2024
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE T...

    • Publication number 20240190858
    • Publication date Jun 13, 2024
    • Tango Therapeutics, Inc.
    • Kimberly Jane Briggs
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN

    • Publication number 20230339915
    • Publication date Oct 26, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

    • Publication number 20230277547
    • Publication date Sep 7, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN

    • Publication number 20230265080
    • Publication date Aug 24, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Upul Keerthi BANDARAGE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE T...

    • Publication number 20230192679
    • Publication date Jun 22, 2023
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATI...

    • Publication number 20230159504
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PYRANO[4,3-B]INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS F...

    • Publication number 20230157999
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Michael Philip CLARK
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING A...

    • Publication number 20230159502
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERI...

    • Publication number 20230159521
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODE...

    • Publication number 20230159580
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS AND METHODS OF USE

    • Publication number 20230113778
    • Publication date Apr 13, 2023
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AND METHODS OF USE

    • Publication number 20230060499
    • Publication date Mar 2, 2023
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AND METHODS OF USE

    • Publication number 20230054084
    • Publication date Feb 23, 2023
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS AND METHODS OF USE

    • Publication number 20220127256
    • Publication date Apr 28, 2022
    • Tango Therapeutics, Inc.
    • Kevin M. Cottrell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS

    • Publication number 20210236505
    • Publication date Aug 5, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20210069203
    • Publication date Mar 11, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    QUINOXALINONE COMPOUNDS, COMPOSITIONS, METHODS, AND KITS FOR INCREA...

    • Publication number 20200361877
    • Publication date Nov 19, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Sudipta MAHAJAN
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20200353101
    • Publication date Nov 12, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick MAXWELL
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20200109130
    • Publication date Apr 9, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20200062732
    • Publication date Feb 27, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20190290654
    • Publication date Sep 26, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20190255062
    • Publication date Aug 22, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180325898
    • Publication date Nov 15, 2018
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180311254
    • Publication date Nov 1, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180208579
    • Publication date Jul 26, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180193341
    • Publication date Jul 12, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS

    • Publication number 20180161336
    • Publication date Jun 14, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE